61 results
8-K
EX-1.1
Zymeworks Inc.
2 Aug 24
Entry into a Material Definitive Agreement
7:10am
responsibility against such losses and risks and in such amounts as are, in the Company’s reasonable judgement, prudent and customary … or fiduciary responsibility in favor of the Company with respect to the transactions contemplated hereby or the process leading thereto (irrespective
424B5
Zymeworks Inc.
2 Aug 24
Prospectus supplement for primary offering
7:00am
or therein or in any free writing prospectuses prepared by us or on our behalf or to which we have referred you. We take no responsibility for, and can … with, or for any other reason by, current or future strategic partners that have responsibility for the clinical development of any of our product candidates
8-K
EX-99.1
Zymeworks Inc.
1 Aug 24
Zymeworks Provides Corporate Update and Reports Second Quarter 2024 Financial Results
4:07pm
and our other partners for research support and other payments. The decrease in revenue from Jazz reflects the transfer of responsibility for certain … in research and development expense was primarily due to a decrease in expenses for zanidatamab as a result of transfer of responsibility
8-K
EX-10.1
76jke
25 Jul 24
Zymeworks Appoints Leone Patterson as Chief Business and Financial Officer
4:35pm
8-K
EX-10.2
u7jozh8l713
25 Jul 24
Zymeworks Appoints Leone Patterson as Chief Business and Financial Officer
4:35pm
424B5
8wfhlcb15oxtrjybcc0k
3 May 24
Prospectus supplement for primary offering
4:17pm
424B5
zmp49fk8h tv7yrl
3 May 24
Prospectus supplement for primary offering
4:11pm
S-3ASR
p5pnkbkq hu
2 May 24
Automatic shelf registration
4:34pm
S-3ASR
EX-4.3
aokf06fztmoney
2 May 24
Automatic shelf registration
4:34pm
8-K
EX-99.1
3ozw50u07d2w
2 May 24
Zymeworks Provides Corporate Update and Reports First Quarter 2024 Financial Results
4:07pm
S-3ASR
gs9szo8jflmx wmfn4jz
7 Mar 24
Automatic shelf registration
4:46pm
S-3
0i11z 90bqmd
6 Mar 24
Shelf registration
5:25pm
8-K
9q0ljy
22 Feb 24
Departure of Directors or Certain Officers
4:15pm